<DOC>
	<DOCNO>NCT00478556</DOCNO>
	<brief_summary>Patients schedule health care provider routine compute tomography ( CT ) scan ask participate study . The primary purpose determine difference patient preference Omnipaque versus Gastroview oral contrast abdominal pelvic CT. A secondary objective evaluate significant difference bowel opacification two agent .</brief_summary>
	<brief_title>Omnipaque Versus Gastroview Oral Contrast Abdominal Pelvic CT</brief_title>
	<detailed_description>Participants must schedule CT scan prior enrollment study . Informed consent obtain patient acceptable include study . It note history gastrointestinal surgery patient nauseate contrast administer . Patients randomize receive either standardized dilution Gastroview Omnipaque orally . The two agent prepare nearly equivalent iodine concentration . No flavor agent ( ie Crystal Light ) add . The plan mix agent per manufacturer recommendation follow : Omnipaque 350 26cc 974 cc water ( 9.0g iodine ) Gastroview 25cc 1000cc water ( 9.17g iodine ) The time patient start stop consuming contrast well volume take time first drink start scan record blinded investigator . Patients ask drink 900cc . Technical staff report side effect complication observe . After completion CT scan , patient fill survey rating taste agent 5 point scale , ask report side effect . Planned rating scale follow : - 2=Dislike much - 1=Dislike moderately 0=Neither like dislike - 1=Like moderately - 2=Like much A taste test two agent administer blinded investigator . Patients give 30 cc agent . The order agent administer randomize . Patients ask rate preference , , either agent 3 point scale . Potential bias relate agent administer CT analyze data . Planned rating scale follow : - 1- A good 0 -no difference - 1- B better Patients contact telephone day CT ass delay side effect diarrhea , constipation , abdominal cramping experience 24 hour follow . Bowel opacification rat 2 body imagers blind agent patient receive . Degree opacification stomach , duodenum , jejunum , ileum rat 4 point scale . If contrast reach colon , ascend , transverse , descend sigmoid similarly evaluate . Four point rating scale follow : 0= absent opacification 1. minimal ( &lt; 25 % analyzed segment opacified ) 2. good ( &gt; 25 % &lt; 75 % analyzed segment opacified ) 3. excellent ( &gt; 75 % analyzed segment opacified ) Description tests/procedures perform . Patients undergo contrast enhance abdominal pelvis CT order refer clinician . Patients randomize either dilute Omnipaque dilute Gastroview oral contrast . Both agent concentration 9 mg iodine/ml , volume 900 cc .</detailed_description>
	<criteria>Patients least 19 year age schedule outpatient contrast enhance abdominal pelvic CT The Kirklin Clinic Birmingham Alabama part clinical care patient 's provider screen eligibility . Not competent give consent . Pregnant . Known allergy either contrast agent . Loss sense taste smell . Contraindication oral administration aspiration risk .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>CT scan</keyword>
	<keyword>oral contrast</keyword>
</DOC>